MBCC: HER2-Positive Breast Cancer Demonstrates Heterogenous Outcomes

from Cancer Network Podcasts · host Cancer Network

The discovery of human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtypes is not yet complete, according to Mark D. Pegram, MD, who will be delivering a presentation on the different clinical outcomes of these subtypes at the Miami Breast Cancer Conference this week.

Episode metadata supplied by the publisher feed · Published Mar 8, 2011

Embed this episode

Attribution link and audio player

NOW PLAYING

MBCC: HER2-Positive Breast Cancer Demonstrates Heterogenous Outcomes

0:00 3:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cancer Network Podcasts?

This episode is 3 minutes long.

When was this Cancer Network Podcasts episode published?

This episode was published on March 8, 2011.

Can I download this Cancer Network Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!